KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Common Equity (2017 - 2025)

Historic Common Equity for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to -$354.5 million.

  • Guardant Health's Common Equity fell 48984.46% to -$354.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$354.5 million, marking a year-over-year decrease of 48984.46%. This contributed to the annual value of -$139.6 million for FY2024, which is 18800.32% down from last year.
  • Guardant Health's Common Equity amounted to -$354.5 million in Q3 2025, which was down 48984.46% from -$305.5 million recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Common Equity registered a high of $847.0 million during Q1 2021, and its lowest value of -$354.5 million during Q3 2025.
  • For the 5-year period, Guardant Health's Common Equity averaged around $192.6 million, with its median value being $158.7 million (2023).
  • Its Common Equity has fluctuated over the past 5 years, first surged by 25327.38% in 2024, then crashed by 1883831.37% in 2025.
  • Quarter analysis of 5 years shows Guardant Health's Common Equity stood at $645.0 million in 2021, then tumbled by 90.67% to $60.2 million in 2022, then skyrocketed by 163.68% to $158.7 million in 2023, then crashed by 188.0% to -$139.6 million in 2024, then tumbled by 153.84% to -$354.5 million in 2025.
  • Its Common Equity stands at -$354.5 million for Q3 2025, versus -$305.5 million for Q2 2025 and -$250.8 million for Q1 2025.